About Human Dopamine Receptor D5 (DRD5) Stable Cell Line

Dopamine Receptor D5 (DRD5), also known as D5 Dopamine Receptor, D5R, or D1B receptor, is a member of the D1-like dopamine receptor family and belongs to the Class A G protein-coupled receptor (GPCR) superfamily. DRD5 is activated by the neurotransmitter dopamine and primarily couples to Gs proteins, leading to stimulation of adenylate cyclase activity and elevation of intracellular cAMP levels. Compared with the closely related D1 receptor (DRD1), DRD5 exhibits higher affinity for dopamine and contributes to the regulation of numerous neurological and physiological processes including cognition, learning, memory, attention, motor control, and neuroendocrine function.

DRD5 is expressed throughout the central nervous system, including the hippocampus, cerebral cortex, hypothalamus, striatum, and limbic regions. Dopaminergic signaling through DRD5 plays important roles in modulating neuronal excitability, synaptic plasticity, and neurotransmitter release. Dysregulation of dopamine receptor signaling has been implicated in several neurological and psychiatric disorders, including schizophrenia, attention-deficit hyperactivity disorder (ADHD), Parkinson's disease, substance abuse, and cognitive dysfunction. Consequently, DRD5 has emerged as an important target for neuroscience research and neuropharmacological drug discovery.

eEnzyme's Human DRD5 Stable Cell Line provides a reliable and reproducible cellular platform for investigating DRD5-mediated signaling pathways and evaluating receptor-targeted therapeutics. The cell line enables quantitative assessment of agonists, antagonists, inverse agonists, and allosteric modulators through cAMP assays, reporter gene assays, and other GPCR functional screening platforms. Researchers can utilize this stable cell line for receptor characterization, compound profiling, potency determination, lead optimization, and high-throughput screening applications targeting neurological and neuropsychiatric disorders.

Applications of the DRD5 Stable Cell Line

• DRD5 receptor pharmacology studies
• Dopamine signaling pathway investigations
• Agonist and antagonist screening
• Neuroscience and neuropsychiatric research
• Parkinson's disease and schizophrenia studies
• ADHD and cognitive disorder research
• cAMP and GPCR signaling assays
• High-throughput screening applications

Biological Significance of DRD5

DRD5 is an important mediator of dopaminergic neurotransmission and contributes to the regulation of cognition, behavior, motor function, and neuroendocrine signaling. Activation of DRD5 stimulates cAMP-dependent pathways that influence neuronal communication, synaptic plasticity, and gene expression. The receptor has been implicated in learning and memory processes, attention regulation, reward pathways, and modulation of movement. In addition to its neurological functions, DRD5 has been reported to participate in cardiovascular regulation, renal physiology, and immune responses. Because dopamine signaling is involved in numerous neurological and psychiatric disorders, DRD5 remains an important target for understanding brain function and developing novel therapeutics for neurodegenerative diseases, psychiatric disorders, and cognitive impairment. The DRD5 Stable Cell Line provides a valuable tool for studying dopamine receptor biology and advancing GPCR-focused drug discovery programs.